Clinical Trial Update: A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating the safety and efficacy of CD-801 in patients with advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CD-801

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Advanced Hepatocellular Carcinoma | EARLY_Phase 1 | Status: COMPLETED